Anxiety has two halves

Anxiety is experienced both mentally and physically. The mental side involves worry, anticipation, difficulty concentrating and a sense of dread. The physical side involves the body's adrenaline response: a pounding heart, trembling hands, sweating, a shaky voice, a churning stomach.

These two halves feed each other. Noticing a racing heart can intensify the mental experience, which in turn drives more adrenaline. That loop is why the physical symptoms are not merely a byproduct.

The two medicines here enter the loop at different points. Propranolol blocks beta-adrenergic receptors, blunting the body's response to adrenaline, so the heart races less and the hands shake less. Hydroxyzine acts on the central nervous system with a sedating, calming effect.

Propranolol does not directly address anxious thinking. Someone taking it may still feel worried while not feeling their heart pound — and for certain situations, particularly performance-related ones, that can be exactly the intended trade-off.

Propranolol for anxiety is off-label

Propranolol's FDA-approved labeling covers primarily cardiovascular indications, with the specific set varying by product. Use for performance anxiety or situational anxiety is generally off-label.

As with any off-label use, this is legal, is common, and is often based on clinical experience — and it means the labeling contains no guidance for that purpose. That makes the prescriber conversation more important than usual, because the usual written reference is silent.

Beta blockers are not suitable for everyone

This deserves emphasis because propranolol is sometimes discussed casually, as though it were a low-stakes option.

Propranolol labeling includes cautions relevant to people with asthma and certain heart conditions. Beta blockade affects the airways as well as the heart, which is why respiratory history matters. It also affects heart rate and blood pressure, which is relevant for people with certain cardiac conditions and for people already taking cardiovascular medicines.

Labeling also warns about abrupt discontinuation. This is not a medicine to start or stop casually, and anyone taking one should know that stopping is a prescriber-managed process.

People with diabetes should be aware that beta blockers can mask some warning signs of low blood sugar — a specific point worth raising directly with a prescriber.

Performance and situational anxiety

Propranolol appears frequently in conversations about performance anxiety — speeches, exams, auditions, interviews — because blunting physical adrenaline symptoms without clouding thinking is a useful combination in those settings.

That use is generally off-label in the United States, meaning official labeling does not describe dosing, timing or expected outcomes for that purpose. Clinical experience supports it in selected patients, but selection is the operative word: a prescriber must weigh respiratory history, heart conditions, blood pressure, other medicines and the specific situation.

Hydroxyzine does the opposite pharmacologically: it sedates the central nervous system. For a performance requiring sharp recall, quick reactions or fine motor control, that profile is usually a poor fit even when anxiety is present. For someone whose primary problem is a generalised state of tension rather than a discrete performance surge, the comparison reverses.

Describing your symptoms as primarily physical, primarily mental, or both — and whether they cluster around specific events — gives a clinician far more to work with than the word "anxiety" alone.

Monitoring and follow-up questions

Beta blockers deserve a monitoring conversation before starting and when anything changes in your health or medicine list.

  • Heart rate and blood pressure. Propranolol affects both. If you already monitor either at home, mention it. Dizziness on standing can relate to blood pressure changes.
  • Respiratory history. Asthma and certain chronic lung conditions matter because beta blockade can affect airways. This is not a medicine to borrow from a friend before a presentation without a personal assessment.
  • Diabetes. Beta blockers can mask some warning signs of low blood sugar. If you have diabetes, raise this explicitly.
  • Stopping. Labeling warns against abrupt discontinuation. Know in advance that stopping is a prescriber-managed process, not something to do when an event is over.
  • Other cardiovascular medicines. Calcium channel blockers, other beta blockers, and some rhythm medicines interact in ways that require professional review.

Hydroxyzine carries a different monitoring profile — sedation, anticholinergic effects, interaction with other depressants — but the principle is the same: a complete list and an explicit conversation beat assumptions.

Different situations, different fit

Rather than ranking them, it is more useful to describe what each is aimed at.

A medicine that blunts physical adrenaline symptoms without sedation suits situations where a person needs to remain fully alert and where the physical symptoms are the main problem. A sedating medicine does not suit a situation requiring sharp performance.

Conversely, where the difficulty is a general state of tension and agitation rather than a discrete physical surge, a peripherally acting medicine addresses less of the picture.

Which description fits your experience is genuinely useful information to bring to an appointment, and it is often more informative than the word "anxiety" alone.